Wednesday, September 16, 2026Latest filing Sep 14, 2026

ALKT Congressional Stock Trades

Alkami Technology, Inc. - Common Stock (ALKT)

Last disclosed trade Apr 30

Every disclosed trade in ALKT by members of Congress under the STOCK Act, parsed by Coldpine. Informational only, sourced from public filings. Not investment advice.

Sample · the intelligence layer

Coldpine signal scoreA 0-1 composite from four weighted factors: disclosure speed, trade size, cluster activity (multiple members buying the same name), and the member’s track record. ≥ 0.65 is the high-conviction tier; ≥ 0.50 is moderate. Trades from trust-managed members are penalized (× 0.2 multiplier). It’s research, not a recommendation.

Gilbert Cisneros · Bought $ALKT · Apr 30 · $1K–$15K

0.57MED
Disclosure speedx 0.251.00
Trade sizex 0.250.20
Cluster activityx 0.150.00
Track recordx 0.350.76

Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →

Follow $ALKT

Get notified when any member of Congress trades $ALKT. Free, no card, no spam.

Follow free →
2
Disclosed trades
2
Buys
0
Sells
1
Members trading

The record on $ALKT

Coldpine has parsed 2 disclosed trades in $ALKT by 1 member of Congress, drawn from 1 periodic transaction report dated Apr 17, 2025 through Apr 30, 2025. All of them came from House members, all filed by Democrats.

Of the 2 trades with a known filing lag, every one was reported inside the STOCK Act's 45-day window. The median lag was 13 days. The longest was 19 days: a $ALKT purchase by Gilbert Cisneros dated Apr 17, 2025, disclosed May 6, 2025. How late filing is measured across all of Congress is in the late-filers study.

Members who trade ALKT

Recent disclosed trades in ALKT

DateMemberTypeAmount
Apr 30Gilbert Cisneros(CA)buy$1K–$15K
Apr 17Gilbert Cisneros(CA)buy$1K–$15K

Data sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores, free with an account →